Targeting Tumor Suppressor Networks for Cancer Therapeutics

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|15|1|2-16

ISSN： 1389-4501

Source： Current Drug Targets, Vol.15, Iss.1, 2014-01, pp. : 2-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Tumor Suppressor p53 for Cancer Therapy: Strategies, Challenges and Opportunities

By  

Current Drug Targets, Vol. 15, Iss. 1, 2014-01 ,pp. : 80-89

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Thematic Issue:Targeting Loss of Tumor Suppressors for Cancer Therapeutics)

By  

Current Drug Targets, Vol. 15, Iss. 1, 2014-01 ,pp. : 1-1

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the LKB1 Tumor Suppressor

By  

Current Drug Targets, Vol. 15, Iss. 1, 2014-01 ,pp. : 32-52

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Tumor Suppressor Dysregulation in Prostate Cancer Progression

By  

Current Drug Targets, Vol. 14, Iss. 4, 2013-04 ,pp. : 460-471

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the ERK Pathway: Novel Therapeutics for Thyroid Cancer

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 4, Iss. 3, 2004-01 ,pp. : 199-220

Bentham Science Publishers

Access to resources Recommend Favorite